Skip to main content
Top
Published in: World Journal of Surgery 2/2020

01-02-2020 | Hyperparathyroidism | Original Scientific Report

Biochemical Profile Affects IOPTH Kinetics and Cure Rate in Primary Hyperparathyroidism

Authors: Claire E. Graves, Catherine M. McManus, John A. Chabot, James A. Lee, Jennifer H. Kuo

Published in: World Journal of Surgery | Issue 2/2020

Login to get access

Abstract

Background

Recently, normocalcemic (NC) and normohormonal (NH) variants of primary hyperparathyroidism (pHPT) have been described, with distinct biochemical profiles from the typical high serum calcium and parathyroid hormone (PTH) levels. Here, we investigate whether biochemical profile affects cure rate, as well as the kinetics of intraoperative PTH (IOPTH).

Methods

This is a single-center, retrospective study of pHPT patients undergoing parathyroidectomy. Patients were grouped based on preoperative calcium and PTH levels into typical, NC (normal calcium, elevated PTH, no evidence of secondary hyperparathyroidism), and NH (elevated calcium, unsuppressed PTH) biochemical profiles. All patients had IOPTH monitoring and ≥6-month post-op serum studies to confirm surgical cure. Patient variables were analyzed with Kruskal–Wallis test and Chi-square analysis. IOPTH kinetic curves were analyzed using a linear mixed model.

Results

From June 2006 to October 2014, 646 patients met inclusion criteria. Biochemical profile was typical in 460 patients (71%), NC in 101 (16%), and NH in 85 (13%). IOPTH levels were higher at all time points in typical patients, p < 0.001. Surgical cure rates were significantly lower for NC patients (90.1%) than for typical (98.5%) or NH patients (97.7%), p < 0.001, although a stricter criteria for cure was used in this group (normal calcium AND normal PTH). In a multivariable linear mixed model, NC patients had a significantly slower rate of IOPTH decline (p < 0.001 at 10 min).

Conclusions

Here, we better characterize the atypical variants of pHPT. Using a stricter definition of cure in the NC variant, these patients have a lower surgical cure rate than typical or NH variants in pHPT. The IOPTH curve is affected by biochemical profile, with both NC and NH patients having lower absolute values and NC patients having a slower decline.
Literature
1.
2.
go back to reference Wilhelm SM, Wang TS, Ruan DT et al (2016) The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151:959–968CrossRef Wilhelm SM, Wang TS, Ruan DT et al (2016) The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151:959–968CrossRef
3.
go back to reference Bilezikian JP, Cusano NE, Khan AA et al (2016) Primary hyperparathyroidism Nat Rev Dis Primers 2:16033CrossRef Bilezikian JP, Cusano NE, Khan AA et al (2016) Primary hyperparathyroidism Nat Rev Dis Primers 2:16033CrossRef
4.
go back to reference Pasieka JL, Parsons L, Jones J (2009) The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study. Surgery 146:1006–1013CrossRef Pasieka JL, Parsons L, Jones J (2009) The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study. Surgery 146:1006–1013CrossRef
5.
go back to reference Silverberg SJ, Clarke BL, Peacock M et al (2014) Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab 99:3580–3594CrossRef Silverberg SJ, Clarke BL, Peacock M et al (2014) Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab 99:3580–3594CrossRef
6.
go back to reference Tassone F, Guarnieri A, Castellano E et al (2015) Parathyroidectomy Halts the deterioration of renal function in primary hyperparathyroidism. J Clin Endocrinol Metab 100:3069–3073CrossRef Tassone F, Guarnieri A, Castellano E et al (2015) Parathyroidectomy Halts the deterioration of renal function in primary hyperparathyroidism. J Clin Endocrinol Metab 100:3069–3073CrossRef
7.
go back to reference Lundstam K, Heck A, Godang K et al (2017) Effect of surgery versus observation: skeletal 5-year outcomes in a randomized trial of patients with primary HPT (the SIPH study). J Bone Miner Res 32:1907–1914CrossRef Lundstam K, Heck A, Godang K et al (2017) Effect of surgery versus observation: skeletal 5-year outcomes in a randomized trial of patients with primary HPT (the SIPH study). J Bone Miner Res 32:1907–1914CrossRef
8.
go back to reference Rao DS, Phillips ER, Divine GW et al (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89:5415–5422CrossRef Rao DS, Phillips ER, Divine GW et al (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89:5415–5422CrossRef
9.
go back to reference Sheldon DG, Lee FT, Neil NJ, et al. (2002) Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg 137:1022–1026 (discussion 1026–1028).CrossRef Sheldon DG, Lee FT, Neil NJ, et al. (2002) Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg 137:1022–1026 (discussion 1026–1028).CrossRef
10.
go back to reference Cheng SP, Lee JJ, Liu TP et al (2015) Quality of Life after surgery or surveillance for asymptomatic primary hyperparathyroidism: a meta-analysis of randomized controlled trials. Medicine (Baltimore) 94:e931CrossRef Cheng SP, Lee JJ, Liu TP et al (2015) Quality of Life after surgery or surveillance for asymptomatic primary hyperparathyroidism: a meta-analysis of randomized controlled trials. Medicine (Baltimore) 94:e931CrossRef
11.
go back to reference Mather HG (1953) Hyperparathyroidism with normal serum calcium. Br Med J 2:424–425CrossRef Mather HG (1953) Hyperparathyroidism with normal serum calcium. Br Med J 2:424–425CrossRef
12.
go back to reference Wills MR, Pak CY, Hammond WG et al (1969) Normocalcemic primary hyperparathyroidism. Am J Med 47:384–391CrossRef Wills MR, Pak CY, Hammond WG et al (1969) Normocalcemic primary hyperparathyroidism. Am J Med 47:384–391CrossRef
13.
go back to reference Siperstein AE, Shen W, Chan AK, et al. (1992) Normocalcemic hyperparathyroidism. Biochemical and symptom profiles before and after surgery. Arch Surg 127:1156–1157 (discussion 1161–1153).CrossRef Siperstein AE, Shen W, Chan AK, et al. (1992) Normocalcemic hyperparathyroidism. Biochemical and symptom profiles before and after surgery. Arch Surg 127:1156–1157 (discussion 1161–1153).CrossRef
14.
go back to reference Lavryk OA, Siperstein AE (2017) Use of calcium and parathyroid hormone nomogram to distinguish between atypical primary hyperparathyroidism and normal patients. World J Surg 41:122–128CrossRef Lavryk OA, Siperstein AE (2017) Use of calcium and parathyroid hormone nomogram to distinguish between atypical primary hyperparathyroidism and normal patients. World J Surg 41:122–128CrossRef
15.
go back to reference Applewhite MK, White MG, Tseng J et al (2017) Normohormonal primary hyperparathyroidism is a distinct form of primary hyperparathyroidism. Surgery 161:62–69CrossRef Applewhite MK, White MG, Tseng J et al (2017) Normohormonal primary hyperparathyroidism is a distinct form of primary hyperparathyroidism. Surgery 161:62–69CrossRef
16.
go back to reference Lim JY, Herman MC, Bubis L et al (2017) Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidism. Surgery 161:70–77CrossRef Lim JY, Herman MC, Bubis L et al (2017) Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidism. Surgery 161:70–77CrossRef
17.
go back to reference Trinh G, Noureldine SI, Russell JO et al (2017) Characterizing the operative findings and utility of intraoperative parathyroid hormone (IOPTH) monitoring in patients with normal baseline IOPTH and normohormonal primary hyperparathyroidism. Surgery 161:78–86CrossRef Trinh G, Noureldine SI, Russell JO et al (2017) Characterizing the operative findings and utility of intraoperative parathyroid hormone (IOPTH) monitoring in patients with normal baseline IOPTH and normohormonal primary hyperparathyroidism. Surgery 161:78–86CrossRef
18.
go back to reference Trinh G, Rettig E, Noureldine SI et al (2018) Surgical management of normocalcemic primary hyperparathyroidism and the impact of intraoperative parathyroid hormone testing on outcome. Otolaryngol Head Neck Surg 159:630–637CrossRef Trinh G, Rettig E, Noureldine SI et al (2018) Surgical management of normocalcemic primary hyperparathyroidism and the impact of intraoperative parathyroid hormone testing on outcome. Otolaryngol Head Neck Surg 159:630–637CrossRef
19.
go back to reference Lee D, Walker MD, Chen HY et al (2019) Bone mineral density changes after parathyroidectomy are dependent on biochemical profile. Surgery 165:107–113CrossRef Lee D, Walker MD, Chen HY et al (2019) Bone mineral density changes after parathyroidectomy are dependent on biochemical profile. Surgery 165:107–113CrossRef
20.
go back to reference Udelsman R, Akerstrom G, Biagini C et al (2014) The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab 99:3595–3606CrossRef Udelsman R, Akerstrom G, Biagini C et al (2014) The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab 99:3595–3606CrossRef
21.
go back to reference Greene AB, Butler RS, McIntyre S et al (2009) National trends in parathyroid surgery from 1998 to 2008: a decade of change. J Am Coll Surg 209:332–343CrossRef Greene AB, Butler RS, McIntyre S et al (2009) National trends in parathyroid surgery from 1998 to 2008: a decade of change. J Am Coll Surg 209:332–343CrossRef
22.
go back to reference Carneiro DM, Solorzano CC, Nader MC, et al. (2003) Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery 134:973–979 (discussion 979–981).CrossRef Carneiro DM, Solorzano CC, Nader MC, et al. (2003) Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery 134:973–979 (discussion 979–981).CrossRef
24.
go back to reference Sokoll LJ, Drew H, Udelsman R (2000) Intraoperative parathyroid hormone analysis: A study of 200 consecutive cases. Clin Chem 46:1662–1668PubMed Sokoll LJ, Drew H, Udelsman R (2000) Intraoperative parathyroid hormone analysis: A study of 200 consecutive cases. Clin Chem 46:1662–1668PubMed
25.
go back to reference Venkat R, Kouniavsky G, Tufano RP et al (2012) Long-term outcome in patients with primary hyperparathyroidism who underwent minimally invasive parathyroidectomy. World J Surg 36:55–60CrossRef Venkat R, Kouniavsky G, Tufano RP et al (2012) Long-term outcome in patients with primary hyperparathyroidism who underwent minimally invasive parathyroidectomy. World J Surg 36:55–60CrossRef
26.
go back to reference Richards ML, Thompson GB, Farley DR et al (2011) An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch Surg 146:280–285CrossRef Richards ML, Thompson GB, Farley DR et al (2011) An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch Surg 146:280–285CrossRef
27.
go back to reference Sho S, Kuo EJ, Chen AC et al (2019) Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism. Ann Surg Oncol 26:539–546CrossRef Sho S, Kuo EJ, Chen AC et al (2019) Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism. Ann Surg Oncol 26:539–546CrossRef
28.
go back to reference Wade TJ, Yen TW, Amin AL et al (2012) Surgical management of normocalcemic primary hyperparathyroidism. World J Surg 36:761–766CrossRef Wade TJ, Yen TW, Amin AL et al (2012) Surgical management of normocalcemic primary hyperparathyroidism. World J Surg 36:761–766CrossRef
Metadata
Title
Biochemical Profile Affects IOPTH Kinetics and Cure Rate in Primary Hyperparathyroidism
Authors
Claire E. Graves
Catherine M. McManus
John A. Chabot
James A. Lee
Jennifer H. Kuo
Publication date
01-02-2020
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 2/2020
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-019-05157-x

Other articles of this Issue 2/2020

World Journal of Surgery 2/2020 Go to the issue